How repeated ankle sprains turn into a cartilage problem

Many patients describe the same pattern: a first bad sprain, a few weeks of rest, then a gradual return to activity — and the quiet realisation, months or years later, that the ankle never quite came back. It gives way on uneven ground, swells after sport, and feels unreliable in a way that earlier sprains never did. What has changed is not simply the ligaments' memory; it is their structure.

The lateral ankle ligaments — principally the ATFL and CFL — are responsible for keeping the talus correctly positioned within the ankle mortise. When they heal in an elongated or weakened state after a significant sprain, they can no longer perform that role reliably. The result is chronic instability: a joint that yields unpredictably under load, particularly on uneven surfaces.

Each giving-way episode is a mechanical event. The talus shifts abnormally and its articular surface absorbs a burst of shear and impact force. The ankle's cartilage surface area is smaller than that of the knee or hip, so even a modest, focal area of damage translates into a disproportionately large functional consequence. Over repeated episodes, the subchondral bone beneath the talar dome may begin to crack, and the overlying cartilage to fragment — the defining features of an osteochondral lesion of the talus (OLT).

This progression is not theoretical. When surgeons perform arthroscopic ligament stabilisation, they routinely inspect the joint for co-existing cartilage damage, and what they find confirms that OLT is a recognised companion to chronic instability — one that often develops in silence long before it announces itself clearly.

What an osteochondral lesion of the talus actually is

Beneath the talar dome lies a thin layer of subchondral bone — the dense, load-bearing plate that sits directly under the articular cartilage. An OLT is, in essence, a crack through that plate with disruption of the cartilage above it. The injury is structurally different from a bruise or a soft-tissue sprain: there is no ligament to scar, no haematoma to resorb. Once the cartilage surface fragments and the underlying bone cracks, the tissue cannot simply recover with rest.

What makes OLT particularly difficult to identify is its early behaviour. In the initial stages, pain during sport or loading is often the only sign — subtle enough to be attributed to residual inflammation or an incompletely healed sprain. Swelling, catching, and the sensation of something locking within the joint tend to appear only as the lesion progresses and fragments become less stable.

Standard ankle X-rays rarely detect these lesions at an early stage; MRI or CT arthrogram is needed to establish the size, depth, and whether the defect is contained. Because the symptoms overlap so closely with ongoing ligament pain, many patients spend months attending physiotherapy before appropriate imaging is arranged and the cartilage injury identified — not through any failure of care, but because the early clinical picture does not distinguish itself clearly from an unresolved sprain.

Symptoms that suggest cartilage involvement, not just instability

Recognising the point at which a stability problem has become a cartilage problem is the practical challenge — and it matters, because the two conditions point toward different treatment paths.

Pure chronic ankle instability typically presents as giving-way, a sense of functional unreliability, and reduced proprioceptive confidence on uneven ground. These symptoms can respond well to targeted rehabilitation: peroneal strengthening, balance training, and neuromuscular re-education. A structured physiotherapy programme is the appropriate first step, and many patients improve meaningfully with it.

Certain features suggest something additional is happening at the cartilage level. Tenderness localised directly over the talar dome — rather than along the lateral ligament itself — is one signal. A catching or clicking sensation within the joint, swelling that seems out of proportion to recent activity, and pain that persists or continues to worsen despite three to six months of well-directed physiotherapy all point toward an osteochondral contribution that rehabilitation alone cannot resolve.

Imaging findings and symptoms do not always align: some patients carry imaging-confirmed lesions with modest functional impact, while others experience significant pain from defects that appear small on MRI. Assessment needs to integrate symptoms, clinical examination, and imaging together — not treat a scan result as a verdict in isolation.

If this pattern of features is present, specialist review is the appropriate next step. The question is not whether physiotherapy was the wrong choice, but whether the ankle has reached a stage that lies beyond what rehabilitation can address.

Why physiotherapy cannot repair cartilage

Structured rehabilitation is the right approach for the instability component of CAI, and the proprioceptive gains it produces are real. The limitation is biological, not therapeutic: articular cartilage has no meaningful blood supply. Without vascular access, it cannot mount the cellular repair response that heals a ligament or a muscle. Exercise, load management, and progressive strengthening — however well-directed — cannot reach a tissue that circulation does not reach.

That structural fact has a specific consequence for OLT. No physiotherapy protocol can consolidate a displaced osteochondral fragment, restore a disrupted articular surface, or reverse damage to the subchondral bone beneath it. These are not rehabilitation goals; they are tissue-engineering problems that exist entirely outside the scope of what any exercise programme is designed to do.

The clinical hazard lies in the trajectory this creates: instability can genuinely improve through rehabilitation while the cartilage lesion below continues to advance. Patients feel better, return to activity, and in doing so deliver further cyclic load to a joint surface that is already compromised. The lesion enlarges, the subchondral bone softens, and — because ankle arthritis is predominantly post-traumatic rather than age-related — the endpoint of that progression is a joint destroyed by the accumulated insult of repeated instability episodes, not by decades of ordinary wear. By the time arthritis is evident on plain imaging, the window for cartilage preservation has already closed.

Treatment options when cartilage damage is confirmed

When an osteochondral lesion is confirmed, treatment decisions are guided by defect size, stability, the degree of subchondral involvement, and whether instability remains a contributing factor.

Biological and injection support

For small, stable lesions that have not displaced, the immediate priority is often reducing the inflammatory load on the joint while protecting the remaining cartilage surface. Platelet-rich plasma (PRP) injection falls into this category: evidence supports a role in dampening inflammation and modulating the joint environment, but it does not restore lost cartilage tissue. This is progression management — not structural repair.

A more targeted option for focal talar defects is an injectable collagen scaffold, delivered as an ultrasound-guided outpatient procedure. The scaffold provides a three-dimensional matrix into which the patient's own progenitor cells can migrate and lay down new cartilage tissue — a matrix-induced chondrogenesis mechanism designed to support tissue regeneration rather than simply manage symptoms. Because treatment is image-guided and outpatient-based, the recovery profile is substantially lighter than theatre-based surgical options.

Surgical options

Surgical treatment is tiered by defect size and characteristics. Arthroscopic debridement and drilling — marrow stimulation techniques — are used for smaller, contained lesions and work by opening channels through the subchondral bone to encourage a healing response. The tissue that forms, however, is fibrocartilage rather than native hyaline cartilage, which is structurally less durable under long-term joint loading. Osteochondral autograft transfer (OATS) addresses this limitation for medium-sized defects: cylindrical plugs of hyaline cartilage are transplanted directly into the talar defect, restoring a more biomechanically appropriate surface. For larger lesions, autologous chondrocyte implantation (ACI) or autologous matrix-induced chondrogenesis (AMIC) offer cell-based or scaffold-based repair, with correspondingly longer recovery timelines.

The instability question

Cartilage repair, at any tier, is incomplete without addressing the underlying instability that caused the lesion. A talar surface that has been treated — by injection or surgery — remains vulnerable to the same cyclic shear and impact loading if the lateral ligaments continue to fail. Ligament reconstruction or repair is often planned in parallel with cartilage treatment precisely for this reason: without it, the mechanical environment that drove the original damage remains unchanged.

Getting assessed at the London Cartilage Clinic

Specialist assessment for suspected talar cartilage damage typically brings together three inputs: a detailed symptom history, clinical examination of ankle stability and joint loading, and cross-sectional imaging — most commonly MRI — to confirm whether a lesion is present and to characterise its size, depth, and containment. Those findings, read alongside the patient's functional status, determine the appropriate next step: conservative management, an injectable scaffold procedure, or surgical referral. The assessment itself is a decision point, not a commitment to any particular pathway.

Patients who have experienced recurrent sprains and whose symptoms extend beyond instability — persistent deep ache, intermittent swelling, catching, or pain that rehabilitation has not resolved — are reasonable candidates for this kind of specialist review, regardless of how long physiotherapy has been the primary approach.

For patients in London, the London Cartilage Clinic on Harley Street offers this assessment and, where appropriate, delivers Liquid Cartilage™ (ChondroFiller injection) under Professor Paul Y. F. Lee, the UK's lead clinician for the procedure. Appointments can be arranged at londoncartilage.com.

1. [1] Sprained Ankle. https://en.wikipedia.org/?curid=5701744 https://en.wikipedia.org/?curid=5701744
2. [2] Knee cartilage replacement therapy. https://en.wikipedia.org/?curid=4984243 https://en.wikipedia.org/?curid=4984243
3. [3] Osteochondritis dissecans. https://en.wikipedia.org/?curid=3762029 https://en.wikipedia.org/?curid=3762029